Dr. Cecilia Pilar Chung Nakandakari is a Miami, Florida based female rheumatologist who is specialized in Rheumatology. Active license number of Dr. Cecilia Pilar Chung Nakandakari for Rheumatology is 48502 in Tennessee. Dr. Cecilia Pilar Chung Nakandakari treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Cecilia Pilar Chung Nakandakari speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Female
Practice Address:
1475 Nw 12th Ave, Miami, Florida, 33136-1002
Phone:
305-243-7545
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1487814166
NPI Enumeration Date:
16 Jun, 2008
NPI Last Update On:
28 Aug, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Cecilia Pilar Chung Nakandakari are as mentioned below.
License Number
Specialization
State
Status
48502
Rheumatologist
Tennessee
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1475 Nw 12th Ave, Miami, Florida
Zip:
33136-1002
Phone Number:
305-243-7545
Fax Number:
--
Patients can reach Dr. Cecilia Pilar Chung Nakandakari at 1475 Nw 12th Ave, Miami, Florida or can call to book an appointment on 305-243-7545. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.